• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Tracey A. Moorhead, President and CEO, DMAA: The Care Continuum Alliance


Tracey Moorhead has expanded membership in the industry's leading DM alliance.

Tracey A. Moorhead
President and CEO, DMAA: The Care Continuum Alliance
Washington, D.C.

Moorhead says the biggest achievement of DMAA has been the development of evidence-based, outcome guidelines used to evaluate DMAA members' programs financially and clinically. The third volume of guidelines, which will include a new emphasis on wellness and health promotion, is due out this September. "We know the impact of chronic disease, but we have not fully identified the value proposition for wellness and disease prevention," she says. "As employers recognize the importance of keeping their workforces healthy, wellness will grow in importance."

Related Content
© 2024 MJH Life Sciences

All rights reserved.